ANVISA registration 80142170076Valid until Jul 28, 2035ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)
ANVISA Registration Number: 80142170076FUNDACAO OSWALDO CRUZFundação Oswaldo Cruz - Instituto de Tecnologia em Imunobiológicos -Risk Class IV
Device names
- Technical name
- ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2)
- Risk class
- Class IV
PT: ANTICORPO PARA VÍRUS DE IMUNODEFICIÊNCIA HUMANA TIPO 1 E TIPO 2 (HIV 1 E HIV 2)
Registration details
- Registration Number
- 80142170076
- Process Number
- 25351449915202446
- CNPJ
- 33781055000135
Company information
- Registration Holder
- FUNDACAO OSWALDO CRUZ
- Manufacturing Country
- Brazil
PT: BRASIL
Dates and status
- Publication Date
- Jul 28, 2025
- Validity
- 28/07/2035
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND HIV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80142170076 and manufactured by Fundação Oswaldo Cruz - Instituto de Tecnologia em Imunobiológicos -. The registration is held by FUNDACAO OSWALDO CRUZ with validity until Jul 28, 2035.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.